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A B S T R A C T
Purpose: To get more insight into molecular mechanisms underlying oxidative stress and its role in
different types of seizure, in this study, oxidative byproducts of proteins, lipids and DNA, as well as,
antioxidant enzyme activities were studied in adult patients with epilepsy.
Methods: Study was performed in 60 patients with epilepsy and in 25 healthy controls. Plasma protein
reactive carbonyl derivatives (RCD) and protein thiol groups (P-SH), byproducts of oxidative protein
damage, as well as antioxidant enzyme activities, superoxide dismutase (SOD) and glutathione
peroxidase (GPX) were studied spectrophotometrically. Urinary 8-epi-prostaglandin F2a (8-epi-PGF2a)
and 8-hydroxy-20-deoxyguanosine (8-OHdG), representative byproducts of lipid and DNA oxidative
damage, respectively, were determined by enzyme immunoassay.
Results: RCD levels were signiﬁcantly increased (p = 0.001), while P-SH content was decreased in
patients with ﬁrst seizure (p = 0.052) compared to controls, independently of the seizure type. Urinary 8-
epi-PGF2a and 8-OHdG were signiﬁcantly increased in patients with epilepsy (p = 0.001 and p = 0.001).
Rise in 8-epi-PGF2a was more pronounced in patients with generalized tonic–clonic seizure (GTCS)
compared to those with partial seizure (PS). Both SOD and GPX activity were signiﬁcantly increased in
epileptic patients compared to controls (p = 0.001 and p = 0.001), but only SOD activity was signiﬁcantly
higher in patients with GTCS than in those with PS.
Conclusions: Data on enhanced protein, lipid and DNA oxidation, together with upregulated antioxidant
enzyme activities, conﬁrm the existence of systemic oxidative stress in patients with epilepsy. It might
be speculated that post-translational modiﬁcation to existing functional proteins, particularly
alterations to ion channels, might be at least partially responsible for acute early changes in neuronal
networks.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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In the last decade, important advances have been made in the
diagnosis and treatment of seizure disorders. However, our
understanding of the cellular and molecular mechanisms under-
lying epileptogenesis, is still incomplete. Among various factors
supposed to play role in epilepsy, the role of oxidative stress and
reactive oxygen species (ROS) in seizure disorders has emerged
recently.1–3 Oxidative stress, recognized as one of the predisposing
factors in various neurological disorders, describes the pathologic
condition in which the balance of oxidant generation and
detoxiﬁcation is tipped toward a prooxidant state, antioxidant
defenses are overwhelmed and reactive species accumulate.4 If left* Corresponding author. Tel.: +381 11 3643249; fax: +381 11 3643270.
E-mail address: marijaercegovac@med.bg.ac.rs (M. Pljesa-Ercegovac).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.02.002unopposed, oxidative stress results in the accumulation of
dysfunctional proteins, lipid peroxidation products and damaged
nuclear or mitochondrial DNA.
The previous ﬁndings on increased oxidative stress in adult
epileptic patients are based on increased plasma malodialdehyde
(MDA) levels, a biomarker of lipid peroxidation.2,5 Accumulation of
ROS byproducts from oxidized genomic DNA has also been
demonstrated in individuals with epilepsy.6,7 However, the data
on isoprostane excretion, the most reliable in vivo marker of lipid
peroxidation and oxidative stress are lacking. In addition, the
action of free radicals, both intracellular and extracellular, is also
directed to proteins as one of themajor target. Moreover, oxidative
damage to proteins is a major mechanism underlying neurode-
generation, which occurs through a variety of pathways including
carbonylation, oxidation of critical sulfhydryl groups and nitrosy-
lation.8 Although epilepsy is not classiﬁed as a neurodegenerative
disease per se, epileptic activity can lead to the cell loss andvier Ltd. All rights reserved.
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Still, there are no reliable data on markers of protein oxidation,
such as protein reactive carbonyl derivatives (RCD) and protein
thiol groups (P-SH) in these patients. In attempt to elucidate
whether changed antioxidant enzyme activities contribute to
oxidative stress in epileptic patients, glutathione peroxidase (GPX)
and superoxide dismutase (SOD), have been investigated much
more, but conﬂicting results have been obtained.1,3,10
Despite many evidences which suggest that epileptic activity is
a state of oxidative stress, the mechanisms by which free radicals
are contributing to seizure disorders remain still elusive. Namely, it
has been reported that increased generation of free radicals or
reduced activity of antioxidative defense mechanisms can cause
some types of epilepsy and in addition, increases the risk of seizure
recurrence.2,11,12 On the other hand, studies in animal models
showed the seizures per se may result in free radical production
and oxidative damage to lipids and DNA.13,14
To get more insight into molecular mechanisms underlying
oxidative stress and its role in different types of seizure, a
systematic investigation of various components of antioxidant
system together with markers of oxidative protein, lipid and DNA
damage in patients with epilepsy is necessary.
In this study, oxidative byproducts of proteins (RCD and SH-
groups), lipids (8-epi-prostaglandin F2a) and DNA (8-hydroxy-2
0-
deoxyguanosine), as well as, antioxidant enzyme activities (SOD
and GPX) were studied in adult patients with epilepsy.
2. Materials and methods
2.1. Selection of study participants
We enrolled 60 patients with ﬁrst unprovoked seizure. The
initial diagnostic process included physical examination, electro-
encephalography and neuroimaging ﬁndings (CT scan and MRI),
performed in all 60 patients, within ﬁrst 24 h after seizure. The
subjectswere 29 (48%)women and 31 (52%)men, aged between 20
and 46 years. Diagnosis of epilepsy was conﬁrmed and limited to
partial cryptogenic or generalized idiopathic seizures, according to
the ILAE classiﬁcation.15 Out of the total number of patients, partial
seizure (motor or complex) occurred in 27 patients (45%), while 33
patients (55%) had primary generalized tonic–clonic seizure.
Duration of partial seizures was from 15 s to 1 min and from
1 min to 2 min in generalized tonic–clonic seizures. None of the
patients had series of seizures or status epilepticus. Exclusion
criteria for the study group were abnormal neurological examina-
tion, abnormal cerebral CT scan andMRI, psychiatric or progressive
neurologic disorders, thyroid diseases and other endocrinopathies,
liver, heart or kidney diseases, or the diseases that could inﬂuence
the level of oxidative stress, such as diabetes mellitus, arterial
hypertension and malignancies. In addition, smokers and alcohol
or narcotic abusers were excluded. The control group consisted of
20 non-epileptic, otherwise healthy subjects, matched for sex and
age. None of the patients or controls received any antiepileptic
drugs or antioxidant supplementation. All subjects gave written
informed consent to participate in the study. The ethics committee
of Faculty of Medicine, University of Belgrade approved the use of
human tissue for research.
2.2. Plasma and urine sampling and analytical procedure
Peripheral venous blood (5 ml) for analysis was collected in
tubes over trace-element free heparin immediately after admis-
sion to Emergency Unit. Plasma was separated at 3000 rpm at 4 8C
during 15 min. The supernatant was collected, aliquoted and
stored at 80 8C for enzyme measurement. Determination of
carbonyl and protein thiol groups was performed immediatelyafter blood collection and plasma separation. Presence of
haemolysis was followed bymeasurement of plasma haemoglobin
and all patients with haemoglobin concentration >50 mg/L were
excluded from the study. Routine biochemical proﬁles were
measured using an autoanalyser.
For 8-epi-prostaglandin F2a and 8-hydroxy-2
0-deoxyguanosine
measurement, urine was collected from all patients and controls.
Samples of 20 ml were centrifuged, aliquoted and stored at80 8C.
Butylated hydroxytoluene was added to prevent oxidation during
processing.
2.3. Laboratory methods
2.3.1. Determination of protein reactive carbonyl derivatives in
plasma
Plasma RCDwere determined using themethod of Levine et al.16
The protein oxidation level was monitored by determination of a
classic carbonyl reagent, 2,4-dinitrophenylhydrazine (DNPH) activ-
ity of proteins. Spectrophotometric measurement of plasma RCD
was performed and expressed as mmol/g proteins. Protein
concentration was determined by the method of Lowry et al.17
2.3.2. Determination of plasma thiol groups
The amount of plasma thiol (P-SH) groups was determined
according to the method of Jocelyn18 and expressed as mmol/g of
proteins (mmol/g prot).
2.3.3. Measurement of urinary 8-epi-prostaglandin F2a
8-Epi-PGF2a was determined by enzyme immunoassay (Biox-
ytech Urinary 8-Epi-prostaglandin F2a kit; Oxis Research, Portland,
OH, USA). The results were standardized against urinary creatinine
concentrations and expressed in ng/mg creatinine.
2.3.4. Measurement of urinary 8-hydroxy-20-deoxyguanosine
8-OHdG was determined by enzyme immunoassay (Bioxytech
8-OHdG-EIA kit; Oxis Research, Portland, OH, USA). The results
were standardized against urinary creatinine concentrations and
expressed in ng/mg creatinine.
2.3.5. Enzyme assays
Cu, Zn SOD activity in the plasma was measured by the method
of Misra and Fridovich,19 based on the ability of SOD to inhibit
autooxidation of epinephrine at alkaline pH (pH 10.2). SOD activity
was determined using the calibrating curve generated by the use of
standard solutions of puriﬁed SOD.
GPX activity was determined by the coupled assay procedure of
Gunzler et al.20 One unit of enzyme activity is reported as mmol
NADPH oxidized per minute, assuming 6.22  103/L/mol/cm to be
the molar absorbancy of NADPH at 340 nm.
2.4. Statistical analysis
Statistical analysis was performed using the Statistical Package
for the Social Sciences software (SPSS, version 10.0; SPSS Inc,
Chicago, IL, USA) and Microcal Origin software (version 5.0). For
each variable, values were expressed as median and conﬁdence
interval. The differences between groups were tested using non-
parametric, Mann–Whitney test. A p value <0.05 was considered
statistically signiﬁcant.
3. Results
3.1. Byproducts of oxidative protein damage in plasma
Data on RCD levels and P-SH content in plasma of controls and
patients with ﬁrst seizure are presented in Table 1. RCD levels were
Table 1
Byproducts of oxidative protein, lipid and DNA damage in controls and in patients with ﬁrst seizure.
Controls (n=20) Patients with ﬁrst seizure (n=60) Type of seizure
PS (n=27) GTCS (n=33)
RCD (mmol/g protein) 0.505a (0.443–0.571) 0.754 (0.664–0.844) 0.704 (0.622–0.89) 0.759 (0.746–0.994)
p 0.001 0.007 0.001
P-SH/P (mmol/g proteins) 7.07 (6.51–7.47) 6.01 (5.98–6.5) 6.14 (6.04–6.8) 6.05 (5.81–6.64)
p NS NS NS
8-Epi-PGF2a (ng/mg creatinine) 0.60 (0.55–0.66) 1.39 (1.29–1.97) 0.93 (0.81–1.57) 1.76
b (1.60–2.37)
p 0.001 0.001 0.001
8-OHdG (ng/mg creatinine) 6.71 (4.33–9.09) 19.5 (15.2–28.2) 14.56 (7.82–30.62) 20.82 (16.6–31.0)
p 0.001 0.001 0.001
RCD: protein reactive carbonyl derivatives; P-SH/P: protein thiol groups per protein concentration; 8-Epi-PGF2a: 8-epi-prostaglandin F2a; 8-OHdG: 8-hydroxy-2
0-
deoxyguanosine; PS: partial seizure; GTCS: generalized tonic–clonic seizure. p: signiﬁcance when compared to controls; NS: no statistical signiﬁcance.
a Data are expressed as median and conﬁdence interval.
b Statistically signiﬁcant when compared to partial seizure.
Fig. 1. Oxidative byproducts of proteins, lipids and DNA in patients with epilepsy. (a) Protein reactive carbonyl derivatives (RCD) in control group and in patients with ﬁrst
seizure; (b) protein thiol groups (P-SH/P) in control group and in patients with ﬁrst seizure; (c) urinary 8-epi-prostaglandin F2a (8-epi-PGF2a) in controls and in patients with
ﬁrst seizure and (d) urinary 8-hydroxy-20-deoxyguanosine (8-OHdG) in controls and in patients with ﬁrst seizure.
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(Fig. 1a), independently of the type of seizure, in comparison to
healthy controls. Plasma protein thiol groups content was lower in
patients with ﬁrst seizure, also irrespectively of the type of seizure,
when compared with controls (Fig. 1b). However, this decrease in
P-SH content was not signiﬁcant.3.2. Byproducts of oxidative lipid damage
The extent of lipid oxidative damage was determined by
measurement of urinary 8-epi-PGF2a, a group of bioactive
prostaglandin F2-like compounds that are generated by oxidatively
catalysed reaction of arachidonic acid. Data on urinary 8-epi-PGF2a
Table 2
Antioxidant enzyme activities in plasma of patients with ﬁrst seizure.
Controls (n=20) Patients with ﬁrst seizure (n=60) Type of seizure
PS (n=27) GTCS (n=33)
SOD (U103/L) 1.21a (0.96–1.42) 2.49 (2.02–2.55) 2.79 (2.39–2.91) 3.15b (2.82–3.49)
p 0.001 0.001 0.001
GPX (U/L) 298 (285–317) 556 (530–566) 590 (569–629) 615 (586–642)
p 0.001 0.001 0.001
SOD: superoxide dismutase; GPX: glutathione peroxidase; PS: partial seizure; GTCS: generalized tonic–clonic seizure. p: signiﬁcance when compared to controls.
a Data are expressed as median and conﬁdence interval.
b Statistically signiﬁcant when compared to partial seizure.
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in Table 1. As shown, urinary 8-epi-PGF2a excretion was
signiﬁcantly, more than 2-fold, increased in patients with seizure
(p = 0.001) (Fig. 1c). Furthermore, urinary 8-epi-PGF2a excretion
was signiﬁcantly higher in patients with the ﬁrst generalized
tonic–clonic seizure in comparison to those with partial seizure
(p = 0.001).
3.3. Byproducts of oxidative damage to DNA
As amarker of oxidative damage to DNA, urinary excretion of 8-
OHdG, a product of oxidatively modiﬁed DNA base guanine, was
determined in patients with ﬁrst seizure (Table 1). Urinary
excretion of 8-OHdG was signiﬁcantly increased (p = 0.001) in
epileptic patients when compared to controls (Fig. 1d). Although 8-
OHdG urinary excretion was higher in patients with generalized
tonic–clonic seizure than in patients with partial seizure, this
difference was not signiﬁcant.
3.4. Plasma antioxidant enzyme activities
Table 2 summarizes the data on antioxidant enzyme activities
in controls and patients with epilepsy. SOD activity was
signiﬁcantly increased in patients with epilepsy in comparison
to controls (p = 0.001), especially in a group of patients with
generalized tonic–clonic seizure, which further signiﬁcantly
differed from patients with partial seizure (p = 0.001). GPX activity
was also signiﬁcantly increased in patients with ﬁrst seizure, when
compared to controls (p = 0.001), but no signiﬁcant difference was
observed in different types of seizure.
4. Discussion
Our study has shown that patients with ﬁrst epileptic seizure
exhibit increased protein damage, based on the increased plasma
RCD content and decreased levels of protein thiol groups. Oxidative
modiﬁcations of proteins are accompanied by signiﬁcant increase in
8-epi-PGF2a and 8-OHdG urinary excretion, indicating increased
lipid and DNA oxidative damage. Furthermore, activities of SOD and
GPX in plasma of these patients are upregulated. The changes in
oxidative stress parametersweremore pronounced in patientswith
generalized tonic–clonic seizures compared to those with partial
seizures, but observed differences reached statistical signiﬁcance
only for urinary 8-epi-PGF2a excretion and plasma SOD activity.
Oxidative stress and generation of reactive oxygen species
(ROS) are strongly implicated in a number of neurological
disorders, including seizure disorders.3 Namely, oxidative reac-
tions occurring in mitochondria produce oxygen radicals physio-
logically in body tissues, as well as, in nervous system cells. If a
strong antioxidant defense system is present in the cells, they will
be protected from the damaging effects of ROS.3,21 Oxidative
damage to proteins is one of the major mechanisms underlying
neuronal cell damage.8 The presence of free radical-initiatedreactions of side chains of amino-acid residues is indicated by
DNPH-reactive carbonyl group of proteins.22 In our study,
signiﬁcant changes in the DNPH activity of plasma proteins have
been shown, to our knowledge, for the ﬁrst time in adult patients
after the ﬁrst seizure. Besides, we demonstrated that the
concentration of protein sulfhydryl groups in plasma, which are
important chain breaking antioxidant,23 is reduced in patients
with ﬁrst seizure. Decreased P-SH levels may be a consequence of
enhanced free radicals production in seizure, since sulfhydryl
groups of plasma proteins have been suggested to be a ‘‘sacriﬁcial’’
antioxidant in plasma and extravascular spaces.23 Until now,
oxidative modiﬁcations of proteins in epilepsy have only been
studied in rodent model of experimental epilepsy, by measure-
ment of thiol redox state in mouse striatum.24 Present results on
increased carbonyl content and enhanced thiol oxidation, appear
to prove the ﬁrst demonstration that increased oxidative damage
of plasma proteins is present in patients with ﬁrst seizure. The
consequences of such oxidative protein damage in epilepsymay be
modiﬁedmembrane and cellular function depending on the nature
of the vulnerable protein component and the attacking radical
species. Itmight be speculated that post-translationalmodiﬁcation
to existing functional proteins, particularly alterations to ion
channels, might be at least partially responsible for acute early
changes in neuronal networks. In addition, the neuronal network
could be previously altered, for still unknown reasons, and more
prone to the oxidative damage, realized after the ﬁrst seizure.
Apart from protein oxidative damage, lipid peroxidation is one
of the most biologically important free radicals reaction.25 If
unopposed with an effective local antioxidative defense system,
peroxidative injury to plasma phospholipidsmay lead to the severe
cell damage. The high rate of oxidative metabolism, coupled with
the low antioxidant defenses and the richness in polyunsaturated
fatty acids, makes the brain highly vulnerable to free radical
damage.26 The increased susceptibility of the brain to oxidative
damage highlights the importance of understanding the role of
oxidative stress in the pathophysiology of seizures. So far,
malodialdehyde (MDA), one of the important aldehydes resulting
from membrane lipid peroxidation products, or peroxidated lipids
(LPO) were used as markers of lipid oxidative damage, both as
measure of lipid peroxidation in brain tissue in ferric chloride and
kainate-induced epilepsy in rats27,28 and in clinical settings.2,5,29
The 8-epi-prostaglandin F2a (8-Epi-PGF2a), a reliable marker of
free radical-induced lipid peroxidation has only been studied in
animal models of epilepsy. Namely, Patel et al.30 examined the
occurrence of oxidant injury following kainate-induced seizure
activity by measuring hippocampal F2-isoprostanes. Our data on
increased levels of urinary 8-Epi-PGF2a in patients with ﬁrst
seizure, especially in those with generalized tonic–clonic seizures,
are in agreementwith ﬁndings of Patel et al.30 who demonstrated a
marked subregion-speciﬁc increase in F2-isoprostanes following
kainate administration. These data suggest that oxidative lipid
damage results from seizure activity and may play an important
role in seizure-induced death of vulnerable neurons.
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endogenous oxidants.31 Although numerous defense systems
protect cellular macromolecules against oxidation, there is a high
rate of damage to DNA. Currently, 8-hydroxydeoxyguanosine, a
product of oxidativelymodiﬁed DNA base guanine, is being used as
a sensitivemarker for oxidative DNAdamage.32 Namely, 8-OHdG is
produced and accumulates at the area of injury, it is secreted into
the bloodstream and is ﬁnally excreted in the urine.6 While
measurement of 8-OHdG in cerebrospinal ﬂuid (CSF) is expected to
be a more sensitive and immediate marker of CNS oxidative stress
than its urinary levels, the collection of CSF is invasive and could be
more stressfull for patients. In addition, urine tends to have more
concentrated levels of 8-OHdG than CSF. Recently, Fukuda et al.7
have demonstrated a statistically signiﬁcant correlation between
urinary and CSF 8-OHdG levels. In accordance to these results, our
data on increased levels of 8-OHdG in patients with ﬁrst seizure
indicate that oxidative stress involves cascade of molecular events
in which all major biological macromolecules are affected.
The question that arises is whether epilepsy or oxidative stress
is the primary event and how the antioxidant enzymes are
involved. Extracellular SOD represents a major defense system
against superoxide, being also a target for oxidative damage.33
Hurd et al.34 have reported an increase in serum extracellular SOD
activity in the progressive myoclonus epilepsies. Similar ﬁndings
were reported by Ben-Menachem et al.35 who found increased
plasma SOD activity, but decreased erythrocyte SOD activity in
patients with progressive myoclonus epilepsies. Our results on
signiﬁcant increase in plasma SOD activity in patients with ﬁrst
unprovoked seizure, especially in those with generalized tonic–
clonic seizures, are in agreement with these ﬁnding. Other studies
on SOD activity have mainly been performed in children with
epilepsy treated by different AEDs,1,10,36 but they reported no
signiﬁcant difference in SOD activity between children with
epilepsy and healthy controls.
The data on anothermajor antioxidant enzyme, GPX, seem to be
conﬂicting too.1,3,35 Extracellular GPX is presumed to work as part
of a traditional glutathione cycle.37 The tripeptide glutathione is
involved in the disposal of peroxides by brain cells and in the
protection against reactive oxygen species, while its content in
brain cells depends strongly on the availability of precursors for
glutathione.38 In vitro extracellular GPX reduces organic hydro-
peroxides, phospholipid hydroperoxides and hydrogen peroxide.39
Studies in mice that overexpress extracellular GPX suggest a
protective extracellular antioxidant activity for extracellular
GPX.40 The pattern of changes observed in our study for plasma
GPX activity in patients with ﬁrst seizure resembles that of SOD.
Namely, we have shown a signiﬁcant increase in plasma GPX
activity and these data are in agreement with ﬁndings of Cengiz
et al.1 who suggested that GPX upregulation might be a
consequence of induced GPX synthesis in a liver as a compensatory
mechanism for decreased glutathione levels detected in the same
group of patients.
Upregulation of plasma SOD and GPX activities in patients with
epilepsy most probably represent an adaptive phenomenon to
increased free radical production in seizure. Despite of high SOD
and GPX activities, accumulated RCD, lipid peroxyl radicals and
their byproducts, such as 8-Epi-PGF2a, as well as, 8-OHdG
overwhelm antioxidant capacity.
5. Conclusion
In conclusion, data on enhanced protein, lipid and DNA
oxidation, together with upregulated antioxidant enzyme
activities, conﬁrm the existence of systemic oxidative stress
in patients with ﬁrst seizure. However, its actual signiﬁcance in
complex cascade of molecular, cellular and neuronal networkalterations must be taken with some caution. Although our
ﬁnding resemble to those in neuronal tissue obtained from
animal models, plasma and urine constituents do not necessarily
reﬂect damage and are not necessarily formed in the region of
tissue damage. To justify association between byproducts of
oxidative damage and seizure, it would be particularly impor-
tant to undertake antioxidant intervention studies, based on
inhibiting oxidative damage and assessment of the impact on
both type and frequency of seizures.
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